Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Some children may develop hair loss after having COVID-19.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

The document's conclusion cannot be summarized because the content is not accessible or understandable.

Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

Most women with hair loss using 5% topical Minoxidil are satisfied with the treatment, but hair loss still affects their daily habits and social life.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Most Indian people with hair loss in the study lacked nutrients, especially iron.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Early diagnosis and a combination of treatments, including minoxidil and finasteride, are recommended for managing hair loss in India.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.